1 |
Adiels M, Taskinen MR, Boren J (2008). Fatty liver, insulin resistance, and dyslipidemia. Curr Diabetes Rep, 8, 60-4.
DOI
|
2 |
Alberti KGM, Zimmet P, Shaw J (2005). The metabolic syndrome: a new worldwide definition. Lancet, 366, 1059-62.
DOI
|
3 |
Angulo P, Hui JM, Marchesini E, et al (2007). The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45, 846-54.
DOI
|
4 |
Bravo AA, Sheth SG, Chopra S (2001). Liver biopsy. N Engl J Med, 344, 495-500.
DOI
|
5 |
Casey SP, Kemp WW, Mclean CA, et al (2012). A prospective evaluation of the role of transient elastography for the detection of hepatitis fibrosis in type 2 diabetes without liver disease. Scand J Gastroenterol, 47, 836-41.
DOI
|
6 |
Chiou WK, Huang BY, Chou WY, et al (2011). Incidences of cancers in diabetic and non-diabetic hospitalized adult patients in Taiwan. Asian Pac J Cancer Prev, 12, 1577-81.
|
7 |
Cusi K (2009). Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes, 16, 141-9.
DOI
|
8 |
Fujino Y (2007). Anthropometry, development history and mortality in the Japan collaborative cohort study for evaluation of cancer (JACC). Asian Pac J Cancer Prev, 8, 105-12.
|
9 |
Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52.
DOI
ScienceOn
|
10 |
Hamer OW, Aguirre DA, Casola G, et al (2006). Fatty liver: Imaging patterns and pitfalls. Radiographics, 26, 1637-53.
DOI
|
11 |
Harris MI, Flegal KM, Cowie CC, et al (1998). Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care, 21, 518-24.
DOI
|
12 |
Hernaez R, Lazo M, Bonekamp S, et al (2011). Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology, 54, 1082-90.
|
13 |
Jacqueminet S, Lebray P, Morra R, et al (2008). Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol, 6, 828-31.
DOI
|
14 |
Jung KS, Kim SU (2012). Clinical applications of transient elastography. Clin Mol Hepatol, 18, 163-73.
DOI
|
15 |
Leite NC, Salles GF, Araujo ALE, et al (2009). Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type2 diabetes mellitus. Liver Int, 29, 113-9.
DOI
ScienceOn
|
16 |
Teli MR, James OF, Burt AD, et al (1995). The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology, 22, 1714-9.
DOI
|
17 |
Poortahmasebi V, Alavian SM, Keyvani H, et al (2014). Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer Prev, 15, 3879-84.
DOI
|
18 |
Schwenzer NF, Springer F, Schraml C, et al (2009). Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol, 51, 433-55.
DOI
|
19 |
Somboon K, Siramolpiwat S, Vilaichone RK (2014). Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand. Asian Pac J Cancer Prev, 15, 3567-70.
DOI
ScienceOn
|
20 |
Tolman KG, Foneca V, Dalpiaz A, et al (2007). Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care, 30, 734-43.
DOI
|
21 |
Trombetta M, Spiazzi G, Zoppini G, et al (2005). Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Alimen Pharmacol Ther, 22, 24-7.
DOI
|
22 |
WHO (2000). World health organisation/international association for the study of obesity/international obesity taskforce. the asia-pacific perspective: redefining obesity and its treatment. http://www.idf.org.au/obesityreport.htm.
|
23 |
Wong VWS, Vergniol J, Wong GLH, et al (2010). Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology, 51, 454-62.
DOI
|
24 |
Younossi ZM, Gramlich T, Matteoni CA, et al (2004). Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol, 2, 262-5.
DOI
|